Mandate

Vinge advises Industrifonden in connection with its investment in Agteria Biotech

Vinge has advised Industrifonden in connection with their participation as lead investor, together with AgriZeroNZ, in the seed financing round in Agteria Biotech AB.

Agteria Biotech AB is a Swedish start-up dedicated to reducing 1% of the global greenhouse gas emissions through its patent-pending molecule that significantly reduces methane emissions from cattle. The new funding will enable the company to advance towards regulatory approval for its methane-reducing molecule, focusing on safety studies for animals, consumers, and the environment.

The Vinge team consisted primarily of JJohan Larsson, Maria Dahlin Kolvik, Ian Linde (M&A), Åsa Hellstadius, Rebecka Målquist (IP), Simon Söderholm and Agnes Pigg (Employment).

Related

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026

Vinge has advised Gamma Waves on Sportway’s EUR 20 million financing round

Vinge has acted as legal adviser to Gamma Waves in connection with Sportway’s EUR 20 million financing round. The round was led by Gamma Waves, together with continued participation from existing shareholders, and values Sportway at approximately EUR 92 million (around SEK 1 billion) post-money.
June 24, 2026

Vinge advises Spotlight Group in connection with offer from Kriptown

Vinge is advising Spotlight Group AB (publ) in connection with Kriptown SAS having made a public cash takeover offer to the shareholders of Spotlight Group
June 17, 2026